With the continual progress of the clinical research industry in India, many large Contract Research Organizations (CROs) have now emerged as full service providers offering drug development from start to finish. But majority of these CROs uphold different units (operating under the same umbrealla) that are neither integrated well nor have good internal communication among themselves. Additionally, they often use subcontractors for managing different services of clinical trails. A for mentioned downsides not only result in poor quality service & failed on-time delivery but also lead to bad customer experience.

Outperforming a bulk of organizations tasting undesired clinical trial results, Milagro Clinical Research(MCR) engraves its uniqueness as an end-to-end service provider for clinical trials (covering phase I-IV) fortified by its quality and on time delivery with exemplary technical knowledge. Besides enhancing its clients’ drug development paradigm’s value with its comprehensive services (project, site, vendor and clinical trial supply management, clinical monitoring, feasibility & study startups and quality assurance/control) and standing

as one-stop-solution through concern process, MCR has also carved its niche in PK-PD & BA/BE Studies, medical writing and pharmaco vigilance & drug safety support services (from preclinical development to post marketing surveillance).

MCR engraves its uniqueness as an end-to-end service provider for clinical trials fortified by its quality and on time delivery with exemplary technical knowledge

Enhancing Customer Experience
Established in 2017, MCR has built a habit of responding quickly to every client while being flexible. This solution oriented firm always strives to find the best approach to fulfill all desires of its partners/clients for clinical trial. MCR’s customized data management solutions emphasize on transparency, integrity and accountability as much as speed & accuracy, whereas its tailor made patient recruitment services take client’s site to enrollment goals in a timely and cost effective manner. “Our recruitment methodologies maximize participation while offering education and support to attract and retain the proper target population to client’s trial,” adds Dr. Anjali Sable, Founder & Director, Milagro Clinical Research. Atop, it renders and supports access to full range of laboratory services dedicated towards clinical development.

To further enhance customer experience, MCR associates with highly skilled investigators

(possessing experience in various specialties) PAN India, who apply high level of expertise as well as state-of-the-art industry best practices for quick & accurate completion of clinical trial. Moreover,it uses recent technologies such as electronic CRF, Risk-Based Monitoring and CTM and renders access to full range of laboratory services dedicated towards clinical development.

Exemplary Quality
From conception of clinical development plans to approval & beyond, MCR renders medical oversight ensuring patient safety, ethical conduct and regulatory compliance. It caters to achieve and sustain utmost effective pharmaco vigilance procedures, which are highly compliant with all the applicable regulatory requirements laid down by FDA, EU and PvPI. On the flip side, MCR’s proficient inhouse regulatory/clinical research team has thorough knowledge and experience of catering to regulatory needs of the drug, irrespective of phase of its life cycle including licensing support, generation of clinical trial regulatory documents and marketing authorization submissions. These highly qualified experts ensure that all procedures are in strict compliance with ICH-GCP, GLP and DCGI guidelines, including the latest amendments to schedule Y of drugs and cosmetic act of clinical trials in India.

Imbibing the nuances in technological trends, MCR is currently focused on deploying remote monitoring and subject level data review for risk assessment. Enriched with such features, this Mumbai-based venture aims to become one of the top 50 CROs in India.